🎧 Listen to this article

Everyone’s talking about Ozempic. Your coworker lost 30 pounds on it. Your sister-in-law is on Wegovy. The ads are everywhere. But here’s what nobody’s discussing at dinner parties: your gut already makes the exact hormone these drugs mimic. Right now. Every time you eat. The problem isn’t that your body lacks the machinery — it’s that you’re not feeding the factory.

What’s actually happening

GLP-1 — glucagon-like peptide-1 — is a hormone produced by specialized cells in your intestinal lining called L-cells. When you eat, these cells release GLP-1, which signals your pancreas to produce insulin, slows gastric emptying so you feel full longer, and communicates directly with your brain’s appetite centers. This is the exact same pathway that semaglutide and tirzepatide activate — except your body does it on its own, continuously, without a prescription.

Here’s where your gut bacteria enter the picture. The trillions of microorganisms living in your intestines don’t just sit there digesting food. They actively drive GLP-1 production through three distinct mechanisms.

Mechanism 1: Short-chain fatty acids. When gut bacteria ferment dietary fiber, they produce short-chain fatty acids (SCFAs) — primarily butyrate, propionate, and acetate. Butyrate is the star here. It activates receptors called FFAR2 and FFAR3 on the surface of your L-cells, which triggers calcium signaling inside the cell and directly stimulates GLP-1 release. A 2025 review confirmed that butyrate doesn’t just trigger a one-time GLP-1 burst — it also increases the expression of the proglucagon gene, which is the blueprint your body uses to manufacture GLP-1 in the first place (Taheri et al., 2025 — https://pmc.ncbi.nlm.nih.gov/articles/PMC11894790/). More fiber in → more butyrate produced → more GLP-1 released. The chain is that direct.

Mechanism 2: Bile acid modification. Your gut bacteria also modify bile acids into secondary forms that activate a receptor called TGR5 on L-cells. TGR5 activation is another independent trigger for GLP-1 secretion. This means your microbiome is pulling two separate levers to boost the same hormone — SCFAs through one receptor pathway, modified bile acids through another.

Mechanism 3: Direct protein secretion. This one is recent and remarkable. A 2021 study in Nature Microbiology found that Akkermansia muciniphila — a bacterium already famous for its role in metabolic health — secretes a specific protein that directly induces GLP-1 production in intestinal cells. Not through SCFAs. Not through bile acids. A literal protein that the bacterium releases, which then tells your L-cells to make more GLP-1 (Yoon et al., 2021 — https://pubmed.ncbi.nlm.nih.gov/33820962/). Your gut bacteria aren’t just helping. They’re running the show.

Why this is happening to you specifically

You eat reasonably well. Maybe you’ve increased your fiber. Maybe you even take a probiotic. But your gut is still inflamed — and inflammation is the wrench in the machinery.

When the intestinal lining is inflamed, L-cells don’t respond to SCFA signals the way they should. The receptors become desensitized. The cells produce less GLP-1 per unit of stimulus. This is the same kind of receptor resistance that happens with cortisol and insulin — your body has the signaling molecule, but the receiving cells have turned down the volume because chronic inflammation told them to.

A 2024 study in mBio mapped the crosstalk between GLP-1 and gut microbiota in metabolic disease and found that dysbiosis — an imbalanced gut bacterial community — directly impairs GLP-1 signaling through inflammatory pathways (Zeng et al., 2024 — https://pubmed.ncbi.nlm.nih.gov/38055342/). So it’s not just about having fiber in your diet. It’s about whether your gut environment is healthy enough to convert that fiber into the SCFAs that trigger GLP-1, and whether your L-cells are uninflamed enough to respond.

This is why two people can eat the same diet and get completely different metabolic outcomes. The difference isn’t willpower or calories. It’s the state of their gut microbiome and whether the GLP-1 factory is operational.

What you can do today

1. Feed the bacteria that make SCFAs. Your GLP-1-producing gut bacteria eat fiber — specifically, resistant starch, inulin, and diverse plant fibers. Oats, cooled potatoes, green bananas, onions, garlic, asparagus, and legumes are top sources. A 2025 review confirmed that dietary fiber intake is the single biggest lever for increasing butyrate production and, consequently, GLP-1 secretion. Aim for 30+ grams of fiber daily from varied sources — diversity matters because different bacteria ferment different fibers.

2. Add fermented foods for bacterial diversity. Yogurt, kefir, sauerkraut, kimchi, and miso introduce Lactobacillus and Bifidobacterium strains that are directly linked to GLP-1 production. A human study found that Lactobacillus reuteri supplementation increased glucose-stimulated GLP-1 by 76% compared to placebo (Simon et al., 2015 — https://pubmed.ncbi.nlm.nih.gov/26374684/). That’s not a marginal effect — that’s your gut bacteria doing what the drugs do, through food.

3. Reduce gut inflammation so your L-cells can actually respond. This means cutting the inputs that damage the intestinal lining: ultra-processed seed oils, excess sugar, alcohol, and chronic NSAID use. It also means adding anti-inflammatory compounds — turmeric (curcumin), omega-3 fatty acids, and polyphenol-rich foods like berries and green tea. Your L-cells need a calm environment to function. Silent inflammation is the reason the factory is running at half capacity.

4. Consider a comprehensive probiotic. If your gut is significantly depleted — from antibiotics, chronic stress, or years of low-fiber eating — food alone may take months to rebuild bacterial diversity. A probiotic with multiple Lactobacillus and Bifidobacterium strains, combined with prebiotics and digestive enzymes, can accelerate the process. IM8’s Essentials Pro combines 10 billion CFU of probiotics, prebiotics, and digestive enzymes with 90 other ingredients in one daily serving — use code Manal10 for 10% off. If you want a more targeted approach, a women’s probiotic focused on gut microbiome diversity or a turmeric probiotic that combines anti-inflammatory support with bacterial restoration both work well.

What to stop doing

Relying on fiber supplements without feeding the bacteria. Psyllium husk adds bulk, but it’s not the same as diverse, fermentable fiber from whole foods. Your GLP-1-producing bacteria need the specific fibers they evolved to ferment — not just any roughage.

Assuming all probiotics are the same. A generic “probiotic” with one or two strains won’t do what a multi-strain formula does. The GLP-1 mechanism involves multiple bacterial species working through different pathways. Lactobacillus for direct GLP-1 stimulation, Bifidobacterium for SCFA production, Akkermansia for the protein pathway. You need coverage across mechanisms, not just a high CFU count on the label.

Ignoring the inflammation underneath. You can eat all the fiber and take all the probiotics you want — but if your gut lining is chronically inflamed from endocrine disruptors, processed food, or unresolved stress, the L-cells won’t respond. The factory needs repair before it can ramp up production.

What we still don’t know

The honest answer: we don’t yet know the optimal dose of specific probiotic strains for sustained GLP-1 elevation in humans. The L. reuteri study showing 76% GLP-1 increase used a specific strain at a specific dose — and that’s one study. The mechanism is clear: gut bacteria produce SCFAs and other metabolites that directly stimulate GLP-1 release from L-cells. The clinical translation — exactly which strains, at what doses, for how long, in which populations — is still being mapped. What we do know is that the gut-GLP-1 axis is real, it’s measurable, and it’s something you can influence starting with your next meal.

Save for later — send to someone who’s considering GLP-1 drugs but hasn’t tried fixing the gut first.